IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Investigation Of Osiris Therapeutics, Inc. And Urges Investors to Contact ...
November 26 2015 - 7:23PM
Business Wire
Lundin Law PC announces it is investigating claims against
Osiris Therapeutics, Inc. (“Osiris” or the “Company”) (NASDAQ:
OSIR) concerning possible violations of federal securities laws.
The investigation is related to allegations that certain statements
issued by Osiris were false and misleading and/or failed to
disclose material information regarding the Company’s financial
performance.
To participate in this class action lawsuit, please contact
Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via
email at brian@lundinlawpc.com.
The investigation will focus on the Company’s announcement that
it has determined to correct the revenue recognition for three
contracts which will result in a decrease in product revenues of
$1.8 million in the first quarter of 2015, a decrease in product
revenues of $1.0 million in the second quarter, an increase in
product revenues of $0.8 million in the third quarter of 2015 and a
decrease in product revenues of $1.1 million in 2014. When the
truth was revealed, shares dropped causing investors harm.
No class has been certified in the above action. Until a class
is certified, you are not considered represented by an attorney.
You may also choose to do nothing and be an absent class
member.
Lundin Law PC was created by Brian Lundin, a securities
litigator based in Los Angeles.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151126005530/en/
Lundin Law PCBrian Lundin, Esq.Telephone: 888-713-1033Facsimile:
888-713-1125brian@lundinlaw.com
Osiris Therapeutics, Inc. (NASDAQ:OSIR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Osiris Therapeutics, Inc. (NASDAQ:OSIR)
Historical Stock Chart
From Apr 2023 to Apr 2024